Center for Transformative Infectious Disease Research: A new approach to preventing vector-borne diseases
Official title: Project 2 - Center for Transformative Infectious Disease Research (CTIDR)
Funded at Cornell University · NIH-11421468 · Data updated 2026-11-12
A community-focused project from Cornell aims to understand how weather, human behavior, and animals influence the spread of diseases carried by mosquitoes and other vectors, with the goal of guiding practical prevention measures.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $258,399 |
| NIH project number | 5P20AI186093-03 |
| Project ID | NIH-11421468 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals living in areas affected by vector-borne diseases and communities participating in or impacted by vector-control efforts.
✕Less likely to help
People in areas without vector-borne disease risk or without access to related interventions may not directly benefit.
What this research studies
This grant supports a team that studies how climate and weather patterns affect mosquitoes and the pathogens they carry, and how people and animals respond to these conditions. Researchers will use field samples, advanced modeling, and pathogen genomics to build models that predict disease risk and guide interventions. The work will also incorporate community insights to ensure interventions fit real-world settings and can be tested in future studies. The project is designed to lay the groundwork for longer-term, transformative approaches to reduce illness from vector-borne diseases in vulnerable populations.
Why it matters
Potential benefit: If successful, this work could lead to better, community-tailored strategies to prevent vector-borne infections.
How similar studies have gone: Previous studies show that integrating environmental data, human behavior, and pathogen genomics can improve understanding of disease risk, though this exact integrated approach is being tested.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Goodman, Laura Brunengraber — Cornell University
- Study coordinator: Goodman, Laura Brunengraber
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.